(Q30671072)

26 June 2017

0 references

Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials (English)

1 reference

26 June 2017

0 references

1 reference

Jie Yang

1

1 reference

26 June 2017

Xiaoyang Cui

2

1 reference

26 June 2017

Jie Li

3

1 reference

26 June 2017

Canfei Zhang

4

1 reference

26 June 2017

Jing Zhang

5

1 reference

26 June 2017

Ming Liu

6

1 reference

26 June 2017

language of work or name

English

0 references

publication date

2 October 2013

1 reference

Developmental Neurorehabilitation

26 June 2017

published in

1 reference

26 June 2017

volume

18

1 reference

26 June 2017

issue

5

1 reference

26 June 2017

page(s)

330-335

1 reference

Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010.

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17518423.2013.830153

From hypertension to stroke: mechanisms and potential prevention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17518423.2013.830153

Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17518423.2013.830153

Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17518423.2013.830153

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17518423.2013.830153

10.3109/17518423.2013.830153

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference